Figure 1

Analytes found in concentrations above the limit of quantification (EQS = EU Environmental quality standards; PFOA = Perfluorooctanoic acid; PFOS = Perfluorooctanesulfonic acid; BPA = Bisphenol A; NP1EO = 4-nonylphenol monoethoxylate; BDE = Brominated diphenylether; PBDEs = Polybrominated diphenyl ethers) compared to limit values (* Default assumption for adults taking into consideration the WHO allocation concept; EQS = environmental quality standards; PV = parametric value according to the EU drinking water directive; GV = WHO guideline value; DWEL = US EPA drinking water equivalent level)_Tabelle 8_ Analyte in Konzentrationen über der Bestimmungsgrenze (EQS = EU-Umweltqualitätsnormen; PFOA = Perfluoroctansäure; PFOS = Perfluoroctansulfonsäure; BPA = Bisphenol A; NP1EO = 4-Nonylphenolmonoethoxylat; BDE = bromierter Diphenylether; PBDE = Polybromierte Diphenylether) im Vergleich zu Grenzwerten (* Standard-Annahme für Erwachsene unter Berücksichtigung des WHO-Zuteilungskonzepts; EQS = Umweltqualitätsnormen; PV = Parameterwert gemäß EU-Trinkwasserrichtlinie; GV = WHO-Richtwert; DWEL = US EPA Trinkwasser--Äquivalenzniveau)_
| Source | Parameter | Number of samples/sources above LOQ/total number | Range/values | PV/GV/DWEL drinking water | Reference |
|---|---|---|---|---|---|
| μg/l | μg/l | ||||
| drinking water | PFOA | 3 out of 20 | 0.0042–0.0107 | 4 | WHO, 2017a |
| bathing water | 2 out of 5 | 0.0040–0.0050 | |||
| groundwater | 7 out of 22 | 0.0026–0.0137 | |||
| river | 1 out of 7 | 0.0032 | |||
| drinking water | PFOS | 3 out of 20 | 0.0029–0.0433 | 0.4 | WHO, 2017a |
| groundwater | 4 out of 22 | 0.0036–0.0373 | |||
| river | 1 out of 7 | 0.0052 | |||
| drinking water | BPA | 4 out of 20 | 0.0075, 0.0089, 0.0131, 0.0209 | 0.01 | EC, 2018b |
| groundwater | 1 out of 22 | 0.0089 | |||
| bathing water | 1 out of 5 | 0.0145 | 0.1 | WHO, 2017a | |
| drinking water | BDE28 | 1 out of 20 | 0.0000088 | 0.018* | ATSDR, 2017 |
| drinking water | BDE 47 | 2 out of 20 | 0.00046–0.00049 | 1.03* | EFSA, 2011 |
| groundwater | 3 out of 22 | 0.00043–0.00062 | |||
| drinking water | BDE 99 | 2 out of 20 | 0.00015–0.00021 | 0.025* | EFSA, 2011 |
| groundwater | 3 out of 22 | 0.00014–0.00025 | |||
| groundwater | BDE 100 | 3 out of 22 | 0.000035–0.000056 | 12* | EPA, 2017 |
| drinking water | 2 out of 20 | 0.000048–0.000049 | |||
| drinking water | BDE 153 | 1 out of 20 | 0.00003 | 0.058* | EFSA, 2011 |
| drinking water | BDE 154 | 1 out of 20 | 0.000029 | 1.2* | EPA, 2017 |
| ground water | 1 out of 22 | 0.000021 | |||
| bathing water | Di-(2-ethylhexyl)phthalate | 1 out of 5 | 0.21 | 8 | WHO, 2017b |
| groundwater | 2 out of 22 | 0.32–0.37 | |||
| drinking water | Di-n-butylphthalate | 1 out of 20 | 0.11 | 40.2* | ECHA, 2016 |
| groundwater | 5 out of 22 | 0.051–0.19 | |||
| drinking water | Diethylphthalate | 1 out of 20 | 0.29 | 3000* | WHO, 2003 |
| bathing water | 2 out of 5 | 0.021–0.052 | |||
| river | 4 out of 7 | 0.021–0.036 | |||
| groundwater | 4 out of 22 | 0.022–0.094 | |||
| groundwater | Benzylbutylphthalate | 1 out of 22 | 0.01 | 3000* | EFSA, 2005 |
| groundwater | Dimethylphthalate | 4 out of 22 | 0.012–0.024 | toxicity less than | US CPSC, 2010 |
| river | 1 out of 7 | 0.013 | other phthalates |
Groundwater: distribution of positive (pos) results among individual samples (abbreviations as used in Table 4)Tabelle 5_ Grundwasser: Verteilung der positiven (pos) Ergebnisse bei einzelnen Proben (Abkürzungen wie in Tabelle 4 verwendet)
| Sample/Param | I | II | III | IV | V | VI | VII | VIII | IX | X | XI | XII | XIII | XIV | XV | XVI | XVII | XVIII | XIX | XX | XXI | XXII | Sum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E1 | |||||||||||||||||||||||
| E2 | |||||||||||||||||||||||
| E3 | |||||||||||||||||||||||
| EE2 | |||||||||||||||||||||||
| PFOA | pos | pos | pos | pos | pos | pos | pos | 7 | |||||||||||||||
| PFOS | pos | pos | pos | pos | 4 | ||||||||||||||||||
| OP | |||||||||||||||||||||||
| BPA | pos | 1 | |||||||||||||||||||||
| BPS | |||||||||||||||||||||||
| TCS | |||||||||||||||||||||||
| OP1EO | |||||||||||||||||||||||
| OP2EO | |||||||||||||||||||||||
| NP1EO | pos | pos | 2 | ||||||||||||||||||||
| NP2EO | |||||||||||||||||||||||
| BDE 100 | pos | pos | pos | 3 | |||||||||||||||||||
| BDE 153 | |||||||||||||||||||||||
| BDE 154 | pos | 1 | |||||||||||||||||||||
| BDE 28 | |||||||||||||||||||||||
| BDE 47 | pos | pos | pos | 3 | |||||||||||||||||||
| BDE 99 | pos | pos | pos | 3 | |||||||||||||||||||
| BBP | pos | 1 | |||||||||||||||||||||
| DEHP | pos | pos | 2 | ||||||||||||||||||||
| DEDP | |||||||||||||||||||||||
| DINP | |||||||||||||||||||||||
| DBP | pos | pos | pos | pos | pos | 5 | |||||||||||||||||
| DOP | |||||||||||||||||||||||
| DEP | pos | pos | pos | pos | 4 | ||||||||||||||||||
| DMP | pos | pos | pos | pos | 4 |
Bathing water: distribution of positive (pos) results among individual samples (abbreviations as used in Table 4)Tabelle 6_ Badegewässer: Verteilung der positiven (pos) Ergebnisse bei einzelnen Proben (Abkürzungen wie in Tabelle 4 verwendet)
| Sample/Param | I | II | III | IV | V | VI | Sum |
|---|---|---|---|---|---|---|---|
| E1 | |||||||
| E2 | |||||||
| E3 | |||||||
| EE2 | |||||||
| PFOA | pos | pos | 2 | ||||
| PFOS | |||||||
| OP | |||||||
| BPA | pos | 1 | |||||
| BPS | |||||||
| TCS | |||||||
| OP1EO | |||||||
| OP2EO | |||||||
| NP1EO | |||||||
| NP2EO | |||||||
| BDE 100 | |||||||
| BDE 153 | |||||||
| BDE 154 | |||||||
| BDE 28 | |||||||
| BDE 47 | |||||||
| BDE 99 | |||||||
| BBP | |||||||
| DEHP | pos | 1 | |||||
| DEDP | |||||||
| DINP | |||||||
| DBP | |||||||
| DOP | |||||||
| DEP | pos | pos | 2 | ||||
| DMP |
Polybrominated diphenylethers (PBDEs): limits of quantification (LOQ)Tabelle 3_ Polybromierte Diphenylether (PBDE): Bestimmungsgrenzen (LOQ)
| LOQ | LOQ | |
|---|---|---|
| Parameter | Period 1 [μg/l] | Period 2 [μg/l] |
| BDE 28 (2,4,4´-Tribromodiphenylether) | 0.0000072 | 0.0000083 |
| BDE 47 (2,2´,4,4´-Tetrabromodiphenylether) | 0.00023 | 0.00025 |
| BDE 99 (2,2´,4,4´,5-Pentabromodi-phenylether) | 0.00020 | 0.00014 |
| BDE 100 (2,2´,4,4´,6-Pentabromodi-phenylether) | 0.000040 | 0.000029 |
| BDE 153 (2,2´,4,4´,5,5´-Hexabromo-diphenylether) | 0.000012 | 0.0000093 |
| BDE 154 (2,2´,4,4´,5,6´-Hexabromo-diphenylether) | 0.000016 | 0.000016 |
Phthalates: limits of detection (LOD) and of quantification (LOQ)Tabelle 2_ Phthalate: Nachweisgrenzen (LOD) und Bestimmungsgrenzen (LOQ)
| Parameter | LOQ [μg/l] | LOD [μg/l] |
|---|---|---|
| Dimethylphthalate | 0.010 | 0.0050 |
| Diethylphthalate | 0.020 | 0.010 |
| Di-n-butylphthalate | 0.050 | 0.025 |
| Benzylbutylphthalate | 0.010 | 0.0050 |
| Di-(2-ethylhexyl)phthalate | 0.20 | 0.10 |
| Di-n-octylphthalate | 0.010 | 0.0050 |
| Di-iso-nonylphthalate | 0.20 | 0.10 |
| Di-iso-decylphthalate | 0.20 | 0.10 |
Drinking water: distribution of positive (pos) results among individual samples (Param_ = test parameter; E1 = Estrone, E2 = Estradiol, E3 = Estriol, EE2 = Ethinylestradiol, PFOA = Perfluorooctanoic acid, PFOS = Perofluorooctanesulfonic acid, OP = 4-tert-octylphenol, BPA = Bisphenol A, BPS = Bisphenol S, TCS = Triclosan, OP1EO = Octylphenol-mono-ethoxylate, OP2EO = Octylphenol-di-ethoxylate, NP1EO = Nonylphenol-mono-ethoxylate, NP2O = Nonylphenol-di-ethoxylate, BDE 100 = 2,2´,4,4´,6-Pentabromodiphenylether, BDE 153 = 2,2´,4,4´,5,5´-Hexabromodiphenylether, BDE 154 = 2,2´,4,4´,5,6´-Hexabromodiphenylether, BDE 28 = 2,4,4´-Tribromodiphenylether, BDE 47 = 2,2´,4,4´-Tetrabromodiphenylether, BDE 99 = 2,2´,4,4´,5-Pentabromodiphenylether, BBP = Benzylbutylphthalate, DEHP = Di-(2-ethylhexyl)phthalate, DEDP = Di-iso-decylphthalate, DINP = Di-iso-nonylphthalate, DBP = Di-n-butylphthalate, DOP = Di-n-octylphthalate, DEP = Diethylphthalate, DMP = Dimethylphthalate)Tabelle 4_ Trinkwasser: Verteilung der positiven (pos) Ergebnisse bei einzelnen Proben (Param_ = Testparameter; E1 = Estron, E2 = Estradiol, E3 = Estriol, EE2 = Ethinylestradiol, PFOA = Perfluoroctansäure, PFOS = Perofluoroctansulfonsäure Säure, OP = 4-tert-Octylphenol, BPA = Bisphenol A , BPS = Bisphenol S , TCS = Triclosan, OP1EO = Octylphenolmonoethoxylat, OP2EO = Octylphenol-diethoxylat, NP1EO = Nonylphenolmonoethoxylat, NP2EO = Nonylphenol-diethoxylat, BDE 100 = 2,2 ', 4,4', 6-Pentabromdiphenylether, BDE 153 = 2,2 ', 4,4', 5,5 '- Hexabromdiphenylether, BDE 154 = 2,2 ', 4,4', 5,6'-Hexabromdiphenylether, BDE 28 = 2,4,4'-Tribromdiphenylether, BDE 47 = 2,2 ', 4,4'-Tetrabromdiphenylether, BDE 99 = 2,2 ', 4,4', 5-Pentabromdiphenyläther, BBP = Benzylbutylphthalat, DEHP = Di-(2-ethylhexyl) phthalat, DEDP = Diisodecylphthalat, DINP = Diisononylphthalat, DBP = Di-n-Butylphthalat, DOP = Di-n-Octylphthalat, DEP = Diethylphthalat, DMP = Dimethylphthalat)
| Sample/Param | I | II | III | IV | V | VI | VII | VIII | IX | X | XI | XII | XIII | XIV | XV | XVI | XVII | XVIII | XIX | XX | Sum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E1 | |||||||||||||||||||||
| E2 | |||||||||||||||||||||
| E3 | |||||||||||||||||||||
| EE2 | |||||||||||||||||||||
| PFOA | pos | pos | pos | 3 | |||||||||||||||||
| PFOS | pos | pos | pos | 3 | |||||||||||||||||
| OP | |||||||||||||||||||||
| BPA | pos | pos | pos | pos | 4 | ||||||||||||||||
| BPS | |||||||||||||||||||||
| TCS | |||||||||||||||||||||
| OP 1EO | |||||||||||||||||||||
| OP2EO | |||||||||||||||||||||
| NP1EO | |||||||||||||||||||||
| NP2EO | |||||||||||||||||||||
| BDE 100 | pos | pos | 2 | ||||||||||||||||||
| BDE 153 | pos | 1 | |||||||||||||||||||
| BDE 154 | pos | 1 | |||||||||||||||||||
| BDE 28 | pos | 1 | |||||||||||||||||||
| BDE 47 | pos | pos | 2 | ||||||||||||||||||
| BDE 99 | pos | pos | 2 | ||||||||||||||||||
| BBP | |||||||||||||||||||||
| DEHP | |||||||||||||||||||||
| DEDP | |||||||||||||||||||||
| DINP | |||||||||||||||||||||
| DBP | pos | 1 | |||||||||||||||||||
| DOP | |||||||||||||||||||||
| DEP | pos | 1 | |||||||||||||||||||
| DMP |
Rivers: distribution of positive (pos) results among individual samples (abbreviations as used in Table 4)Tabelle 7_ Flüsse: Verteilung der positiven (pos) Ergebnisse bei einzelnen Proben (Abkürzungen wie in Tabelle 4 verwendet)
| Sample/Param | I | II | III | IV | V | VI | VII | Sum |
|---|---|---|---|---|---|---|---|---|
| E1 | ||||||||
| E2 | ||||||||
| E3 | ||||||||
| EE2 | ||||||||
| PFOA | pos | 1 | ||||||
| PFOS | pos | 1 | ||||||
| OP | ||||||||
| BPA | ||||||||
| BPS | ||||||||
| TCS | ||||||||
| OP1EO | ||||||||
| OP2EO | ||||||||
| NP1EO | pos | 1 | ||||||
| NP2EO | ||||||||
| BDE 100 | ||||||||
| BDE 153 | ||||||||
| BDE 154 | ||||||||
| BDE 28 | ||||||||
| BDE 47 | ||||||||
| BDE 99 | ||||||||
| BBP | ||||||||
| DEHP | ||||||||
| DEDP | ||||||||
| DINP | ||||||||
| DBP | ||||||||
| DOP | ||||||||
| DEP | pos | pos | pos | pos | 4 | |||
| DMP | pos | 1 |
Selected analytes with corresponding internal standardsTabelle 1_ Ausgewählte Analyten mit den jeweiligen internen Standards
| Analyte | Internal Standards | LOQ [ng/l] | LOD [ng/l] |
|---|---|---|---|
| Estrone (E1) | Estrone-D4 | 0.13 | 0.035 |
| Estradiol (E2) | Estradiol-D4 | 0.11 | 0.030 |
| Estriol (E3) | Ethinylestradiol-D7 | 0.44 | 0.118 |
| Ethinylestradiol (EE2) | Ethinylestradiol-D7 | 0.084 | 0.023 |
| Bisphenol A (BPA) | Bisphenol A-D16 | 6.5 | 1.8 |
| Bisphenol S (BPS) | Bisphenol A-D16 | 6.2 | 1.7 |
| Triclosan (TCS) | Triclosan-D3 | 3.3 | 0.9 |
| Perfluorooctanoic acid (PFOA) | Perfluorooctanoic acid-13C8 | 1.95 | 0.5 |
| Perofluorooctanesulfonic acid (PFOS) | Perofluorooctanesulfonic acid-13C8 | 2.8 | 0.77 |
| Nonylphenol-mono-ethoxylate (NP1EO) | Atrazin-D5 | 8.9 | 2.5 |
| Nonylphenol-di-ethoxylate (NP2EO | Atrazin-D5 | 6.9 | 1.9 |
| 4-tert-octylphenol (4-tert.-OP) | 4-tert-octylphenol-D2 | 3.7 | 1.0 |
| Octylphenol-mono-ethoxylate (OP1EO) | Atrazin-D5 | 8.20 | 1.7 |
| Octylphenol-di-ethoxylate (OP2EO) | Atrazin-D5 | 6.2 | 1.3 |